Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open-label, single arm, multicenter clinical study to evaluate the
safety, tolerability, efficacy mitoxantrone hydrochloride liposome in combination with
gemcitabine, dexamethasone, and cisplatin in relapsed/refractory peripheral T-cell lymphoma